Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ASTRAZENECA PHARMA WOCKHARDT/
ASTRAZENECA PHARMA
 
P/E (TTM) x -16.8 95.5 - View Chart
P/BV x 2.7 22.7 11.8% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 WOCKHARDT   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-23
ASTRAZENECA PHARMA
Mar-23
WOCKHARDT/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs3163,620 8.7%   
Low Rs1452,438 6.0%   
Sales per share (Unadj.) Rs184.0401.2 45.9%  
Earnings per share (Unadj.) Rs-43.139.7 -108.5%  
Cash flow per share (Unadj.) Rs-25.746.2 -55.6%  
Dividends per share (Unadj.) Rs016.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs231.7234.4 98.8%  
Shares outstanding (eoy) m144.0925.00 576.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.37.5 16.6%   
Avg P/E ratio x-5.376.3 -7.0%  
P/CF ratio (eoy) x-9.065.5 -13.7%  
Price / Book Value ratio x1.012.9 7.7%  
Dividend payout %040.3 -0.0%   
Avg Mkt Cap Rs m33,20275,718 43.8%   
No. of employees `000NANA-   
Total wages/salary Rs m6,3702,591 245.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m26,51010,030 264.3%  
Other income Rs m1,220261 467.4%   
Total revenues Rs m27,73010,291 269.5%   
Gross profit Rs m-1,9301,249 -154.5%  
Depreciation Rs m2,510163 1,543.7%   
Interest Rs m3,0206 47,936.5%   
Profit before tax Rs m-6,2401,341 -465.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-30348 -8.6%   
Profit after tax Rs m-6,210993 -625.4%  
Gross profit margin %-7.312.5 -58.5%  
Effective tax rate %0.526.0 1.9%   
Net profit margin %-23.49.9 -236.6%  
BALANCE SHEET DATA
Current assets Rs m19,1409,359 204.5%   
Current liabilities Rs m34,3504,844 709.1%   
Net working cap to sales %-57.445.0 -127.4%  
Current ratio x0.61.9 28.8%  
Inventory Days Days3949 79.6%  
Debtors Days Days1139 28.0%  
Net fixed assets Rs m48,6702,061 2,361.0%   
Share capital Rs m72050 1,440.0%   
"Free" reserves Rs m32,6605,811 562.0%   
Net worth Rs m33,3805,861 569.5%   
Long term debt Rs m2,2400-   
Total assets Rs m70,75011,421 619.5%  
Interest coverage x-1.1213.9 -0.5%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.40.9 42.7%   
Return on assets %-4.58.7 -51.5%  
Return on equity %-18.616.9 -109.8%  
Return on capital %-9.023.0 -39.3%  
Exports to sales %00-   
Imports to sales %3.537.4 9.3%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m9203,747 24.6%   
Fx inflow Rs m730612 119.3%   
Fx outflow Rs m9203,747 24.6%   
Net fx Rs m-190-3,135 6.1%   
CASH FLOW
From Operations Rs m1,530583 262.5%  
From Investments Rs m-1,250181 -690.2%  
From Financial Activity Rs m-3,150-245 1,286.8%  
Net Cashflow Rs m-2,800519 -539.3%  

Share Holding

Indian Promoters % 54.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.5 5.4 82.7%  
FIIs % 4.2 2.7 156.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.1 25.0 180.3%  
Shareholders   161,813 29,032 557.4%  
Pledged promoter(s) holding % 74.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Wockhardt vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Wockhardt vs ASTRAZENECA PHARMA Share Price Performance

Period Wockhardt ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 4.99% 0.01% 1.18%
1-Month 0.15% -3.61% -0.75%
1-Year 290.07% 59.20% 61.82%
3-Year CAGR 13.79% 20.50% 18.16%
5-Year CAGR 7.92% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the Wockhardt share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of Wockhardt hold a 54.9% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Wockhardt and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Wockhardt paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of Wockhardt, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.